Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
AdipoGen Life Sciences
Carboplatin
45
CHF
CHF 45.00
In stock
AG-CR1-3591-M02525 mgCHF 45.00
AG-CR1-3591-M100100 mgCHF 150.00
AG-CR1-3591-M250250 mgCHF 290.00
| Product Details | |
|---|---|
| Synonyms | cis-Diammine(cyclobutane-1,1-dicarboxylate-O,O')platinum(II); NSC201345; NSC241240; JM-8; Paraplatin; Cbdca |
| Product Type | Chemical |
| Properties | |
| Formula |
C6H12N2O4Pt |
| MW | 371.3 |
| Merck Index | 14: 1822 |
| CAS | 41575-94-4 |
| RTECS | TP2300000 |
| Purity Chemicals | ≥98% |
| Appearance | White to off-white powder. |
| Solubility | Soluble in water. |
| Identity | Determined by 1H-NMR. |
| InChi Key | YAYRGNWWLMLWJE-UHFFFAOYSA-L |
| Smiles | N[Pt]1(N)OC(=O)C2(CCC2)C(=O)O1 |
| Shipping and Handling | |
| Shipping | AMBIENT |
| Short Term Storage | +4°C |
| Long Term Storage | -20°C |
| Handling Advice |
Keep cool and dry. Protect from light and moisture. |
| Use/Stability | Stable for at least 2 years after receipt when stored at -20°C. |
| Documents | |
| MSDS |
 Download PDF |
| Product Specification Sheet | |
| Datasheet |
Download PDF |
Description
- Potent platinum-based antineoplastic agent. Analog of cisplatin (Prod. No. AG-CR1-3590) with reduced nephrotoxicity and higher stability.
- Antitumor agent.
- Forms inter- and intrastrand DNA adducts/crosslinks, consequently blocking DNA replication and transcription and inducing cell death.
- Interferes with cell division by mitosis. The damaged DNA elicits DNA repair mechanisms, which in turn activate apoptosis when repair is impossible.
- Apoptosis inducer.
- Enhances radiation-induced single-strand DNA breakage.
- Chk2 inhibition with carboplatin selectively kills Wwox-deficient cells
Product References
- Pharmacokinetics of cis-diammine-1,1-cyclobutane dicarboxylate platinum(II) in patients with normal and impaired renal function: S.J. Harland, et al.; Cancer Res. 44, 1693 (1984)
- Carboplatin: a very active new cisplatin analog in the treatment of small cell lung cancer: I.E. Smith, et al.; Cancer Treat Rep. 69, 43 (1985)
- Carboplatin (JM8) as a single agent and in combination in the treatment of small cell lung cancer: I.E. Smith & B.D. Evans; Cancer Treat Rev. 12 (Suppl. A), 73 (1985)
- Carboplatin enhances the production and persistence of radiation-induced DNA single-strand breaks: L.X. Yang, et al.; Radiation Res. 143, 302 (1995)
- Increased DNA-binding activity of cis-1,1-cyclobutanedicarboxylatodiammineplatinum (II) (carboplatin) in the presence of nucleophiles and human breast cancer MCF-7 cell cytoplasmic extracts: activation theory revisited: G. Natarajan, et al.; Biochem. Pharmacol. 58, 1625 (1999)
- Mechanisms of reaction of L-methionine with carboplatin and oxaliplatin in different media: a comparison with cisplatin: O. Heudi, et al.; Biopharm. Drug Dispos. 20, 107 (1999)
- What is the "best" platinum: cisplatin, carboplatin, or oxaliplatin? J. Lokich; Cancer Invest. 19, 756 (2001)
- New clues for platinum antitumor chemistry: Kinetically controlled metal binding to DNA: J. Reedijk; PNAS 100, 3611 (2003)
- High accumulation of platinum-DNA adducts in strial marginal cells of the cochlea is an early event in cisplatin but not carboplatin ototoxicity: J.P. Thomas, et al.; Mol. Pharmacol. 70, 23 (2006)
- p53 regulates ERK activation in carboplatin induced apoptosis in cervical carcinoma: A novel target of p53 in apoptosis: S. Singh, et al.; FEBS Lett. 581, 289 (2007)
- Inhibition of transcription by platinum antitumor compounds: R.C. Todd & S.J. Lippard; Metallomics 1, 280 (2009)
- Application of electric cell-substrate impedance sensing toward personalized anti-cancer therapeutic selection: A.F. Adcock, et al.; J. Analyt. Sci. Tec. 9, 17 (2018)
- Novel FOXM1 inhibitor identified via gene network analysis induces autophagic FOXM1 degradation to overcome chemoresistance of human cancer cells: M.S. Chesnokov, et al.; Cell Death Dis. 12, 704 (2021)
- Interaction of Wwox with Brca1 and associated complex proteins prevents premature resection at double-strand breaks and aberrant homologous recombination: D. Park, et al.; DNA Rep. in press (2021)
Related Products
